Correlation Between NYSE Composite and Lisata Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Lisata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Lisata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Lisata Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Lisata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Lisata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Lisata Therapeutics.
Diversification Opportunities for NYSE Composite and Lisata Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NYSE and Lisata is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Lisata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lisata Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Lisata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lisata Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Lisata Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Lisata Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.2 times more return on investment than Lisata Therapeutics. However, NYSE Composite is 5.1 times less risky than Lisata Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Lisata Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 1,547,479 in NYSE Composite on August 26, 2024 and sell it today you would earn a total of 464,866 from holding NYSE Composite or generate 30.04% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Lisata Therapeutics
Performance |
Timeline |
NYSE Composite and Lisata Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Lisata Therapeutics
Pair trading matchups for Lisata Therapeutics
Pair Trading with NYSE Composite and Lisata Therapeutics
The main advantage of trading using opposite NYSE Composite and Lisata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Lisata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lisata Therapeutics will offset losses from the drop in Lisata Therapeutics' long position.NYSE Composite vs. Glacier Bancorp | NYSE Composite vs. LithiumBank Resources Corp | NYSE Composite vs. Stepstone Group | NYSE Composite vs. Pintec Technology Holdings |
Lisata Therapeutics vs. Lixte Biotechnology Holdings | Lisata Therapeutics vs. Histogen | Lisata Therapeutics vs. Imunon Inc | Lisata Therapeutics vs. Kineta Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |